Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 моноклональный антитело that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1.
Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.